Real-world comparison of treatments with antibodies targeting the CGRP pathway or botulinum toxin type A for resistant migraine
Authors:
Posted in Papers / Human Studies|Original Research / December 1-15, 2025
Rev Neurol (Paris). 2025 Dec 11:S0035-3787(25)00649-6. doi: 10.1016/j.neurol.2025.10.006. Online ahead of print.
PMID: 41387033 | DOI: 10.1016/j.neurol.2025.10.006
Share this article
Sign Up For An MSC Newsletter
Register to Watch the MSC Emerging Science Contest!
The MSC Emerging Science Contest for Young Investigators will take place on Wednesday, December 13, 2023, from 8-10 PM Eastern (US) time. We welcome those who wish to watch the event as an attendee. Register here to attend, and learn more about the contest here.